Sphingolipids in Cancer, Vol 140. Advances in Cancer Research

  • ID: 4465334
  • Book
  • 312 Pages
  • Elsevier Science and Technology
1 of 3

Sphingolipids in Cancer, Volume 140, the latest release in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research. Topics discussed in this updated volume include Mechanisms of ceramide-dependent cancer cell death, Sphingolipids as regulators of autophagy and endocytic trafficking, The role and function of sphingomyelin biosynthesis in the development of cancer, Neutral sphingomyelinases in cancer: Friend or foe?, Sphingolipid rendezvous at the crossroad of NAFLD and senescence, Ceramide signaling and p53 pathways, Sphingolipid regulation of RNA Biology in cancer phenotypes, The role of ceramide-1-phosphate in tumor cell survival and dissemination, and more.

  • Provides information on cancer research, with this release focusing on sphingolipids
  • Offers outstanding and original reviews on a range of cancer research topics
  • Serves as an indispensable reference for researchers and students alike
Note: Product cover images may vary from those shown
2 of 3
- Mechanisms of ceramide-dependent cancer cell death

Rose Nganga, Natalia Oleinik and Besim Ogretmen

- Sphingolipids as regulators of autophagy and endocytic trafficking

Megan M. Young and Hong-Gang Wang

- Role and function of sphingomyelin biosynthesis in the development of cancer

Giovanni D'Angelo, Sitapriya Moorthi and Chiara Luberto

- Neutral sphingomyelinases in cancer: friend or foe?

Christopher J. Clarke

- Ceramide and exosomes: a novel target in cancer biology and therapy

Ahmed Elsherbini and Erhard Bieberich

- Sphingolipids at the crossroads of NAFLD and senescence

Mariana Nikolova-Karakashian

- Ceramide signaling and p53 pathways

Kristen Jeffries and Natalia Krupenko

- The role of ceramide 1-phosphate in tumor cell survival and dissemination

Antonio Gomez-Muñoz

- The onus of sphingolipid enzymes in cancer drug resistance

Samy A.F. Morad and Myles C. Cabot

- Interdiction of sphingolipid metabolism revisited: focus on prostate cancer

Christina Voelkel-Johnson, James S. Norris and Shai White-Gilbertson

- Targeting sphingosine kinases for the treatment of cancer

Clayton S. Lewis, Christina Voelkel-Johnson and Charles D. Smith

- Novel sphingolipid-based cancer therapeutics in the personalized medicine era

Jeremy Shaw, Pedro Costa-Pinheiro, Logan Patterson, Kelly Drews, Sarah Spiegel and Mark Kester

- Side effects in cancer therapy: are sphingolipids to blame?

Falak Patel and Stefka D. Spassieva
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll